Compounds > n-methyl-3,4-methylenedioxyamphetamine
Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Cardiomyopathies, Primary

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Cardiomyopathies, Primary in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koczor, CA1
Ludlow, I1
Hight, RS1
Jiao, Z1
Fields, E1
Ludaway, T1
Russ, R1
Torres, RA1
Lewis, W1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Cardiomyopathies, Primary

ArticleYear
Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart.
    Toxicological sciences : an official journal of the Society of Toxicology, 2015, Volume: 148, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Cardiomyopathies; Cardiotoxins; Circadian Rhythm Signaling Peptides a

2015